Malaria PRESENTATION.pptx

Malaria
MALARIA CLINICAL PREASENTION, INVESTIGATION AND
TREATMENT
BY ALINISWE NG’AMBI
How Malaria present Clinically
 Stage 1(cold stage)
 Chills for 15 mt to 1 hour
 Caused due to rupture from the host red cells
escape into Blood.
 Preset with nausea, vomitting, headache
 Stage 2(hot stage)
• Fever may reach upto 400c may last for several hours starts invading newer red
cells
 Stage 3(sweating stage)
• Patent starts sweating, concludes the episode
• Cycles are frequently Asynchronous
• Paroxysms occur every 48 – 72 hours
• In P.malariae pyrexia may last for 8 hours or more and temperature my
exceed 410c
More commonly, the patient presents with
a combination of the following symptoms
 Chills
 Sweats
 Fever
 Headaches
 Nausea and vomiting
 Body aches
 General malaise.
SEVERE COMPLICATED MALARIA
 Alteration in the level of consciousness (ranging from drowsiness to
deep coma)
 Cerebral malaria (unarousable coma not attributable to any other
cause in a patient with falciparum malaria)
 Respiratory distress (metabolic acidosis bicarb less than 15 meq/l)
 Multiple generalized convulsions (2 or more episodes within a 24
hour period) Shock (circulatory collapse, septicemia)
 Pulmonary edema
 Abnormal bleeding (Disseminated Intravascular coagulopathy)
 Jaundice
SEVERE COMPLICATED MALARIA
 Haemoglobinuria (black water fever)
 Acute renal failure - presenting as oliguria or anuria
 Severe anaemia (Haemoglobin < 5g/dl or Haematocrit <
15%)
 High fever
 Hypoglycaemia (blood glucose level < 2.2.mmol/l) defined
as the detection of P. falciparum in the peripheral blood
INVESTIGATIONS AND LABS
•Baseline study
 CBC: Hemolytic anaemia: Hb, LDH, indirect bilirubin.
 Leukocytosis or leukopenia are uncommon except in severe disease
 Urinalysis:hemoglobinuria may occur with intravascular hemolysis
 OTHERS; LFT and Coagulation panel to evaluate for organ funtion
•Blood film examination(Microscopy)
• Rapid Diagnostic Tests" (RDTs)
• PCR
BLOOD FILM(THIN AND THICK SMEAR)
STAINING WITH GIEMSA STAIN
Antigen Detection
• These "Rapid Diagnostic Tests" (RDTs). Rapid diagnostic
tests (RDTs) are immunochromatographic tests based on
detection of specific parasite antigens. Tests which detect
histidine-rich protein 2 (HRP2) are specific for P.falciparum
while those that detect parasite lactate dehydrogenase
(pLDH)-OptiMAL
Molecular Diagnosis
• Parasite nucleic acids are detected using polymerase chain
reaction (PCR). This technique is more accurate than
microscopy. However, it is expensive, and requires a
specialized laboratory (even though technical advances will
likely result in field-operated PCR machines).
Treatment of uncomplicated p.falciparum
• Artemether plus lumefantrine( COARTEM)
• Weight Tablets Day 1 Day 2 Day3
• 5-14kgs 1 tab 1 tab 1 tab then 8hr Q12H Q12H
• 15-24kgs 2 tab 2 tab 2 tab then 8hr Q12H Q12H
• 25-34kgs 3 tab 3 tab 3 tab then 8hr Q12H Q12H
• > 34 Kgs 4 tab 4 tab 4 tab then 8hr Q12H Q12H
Treatment of severe falciparum malaria
Preferred regime
• IV Artesunate (60mg): 2.4mg/kg on admission, followed by 2.4mg/kg at 12h & 24h, then once
daily for 7 days.
• Once the patient can tolerate oral therapy, treatment should be switched to a complete dosage
of Coartem (artemether/lumefantrine) for 3 day.
• Reconstitute with 5% Sodium Bicarbonate & shake 2-3min until clear solution obtained. Then
add 5ml of D5% or 0.9%NaCl to create total volume of 6ml.
• Slow IV injection with rate of 3-4ml/min or IM injection to the anterior thigh. The solution
should be prepared freshly for each administration & should not be stored. Pregnant women &
child < 8yrs old: Clindamycin (10mg/kg twice daily). Both drug can be given for 7 days
• ALTERNATIVE REGIME
• IV Quinine loading 7mg salt /kg over 1hr followed by infusion quinine 10mg salt/kg over 4 hrs,
then 10mg salt/kg Q8H or IV Quinine 20mg/kg over 4 hrs, then 10mg/kg Q8H. PLUS
• Adult and child > 8yrs old ; doxycycline( 3.5 mg/kg once daily)
• Dilute injection quinine in 250ml od D5% and infused over 4hrs.
• Infusion rate should not exceed 5 mg salt/kg per hour
FOR UNDER FIVES
Children under 5 kg or below 4 months should not be given
Coartem instead treat with the following regimen (see table).
Age Group
Weight
group
Artesunate or *Quinine
0 - 4
months
<5 kg
** IM first dose
Artesunate 1.2
mg/kg or IM
Arthemeter 1.6
mg/kg)
***Oral
Artesunate
2mg/kg/day
day 2 to day 7
Oral
Quinine 10
mg/kgTDS
for 4 days
then 15-20
mg/kg TDS
for 4 days
SPECIFIC POPULATION
• Specific Preferred regime Alternative regime populations
• Pregnancy Quinine plus clindamycin to be given for Artesunate plus Clindamycin
7 day for 7 days is indicated if first
line treatment fails
• Lactating woman; Should receive standard antimalarial treatment (including ACTs) except for dapsone,
primaquine and tetracyclines, which should be withheld during lactation
• Hepatic Chloroquine: 30-50% is modified by liver, appropriate dosage adjustment impairment is needed,
monitor closely.
• Quinine : Mild to moderate hepatic impairment-no dosage adjustment, monitor closely.
• Artemisinins : No dosage adjustment
• Renal Chloroquine : ClCr<10ml/min-50% of normal dose.
Impairment Hemodialysis, peritoneal dialysis: 50% of normal dose.
Continuous Renal Replacement Therapy(CRRT) :100% of normal dose
Quinine : .ClCr 10-50ml/min : Administer Q8-12H, CLCr<10ml/min administer Q24H
,Severe chronic renal failure not on dialysis : initial dose: 600mg followed by 300mg Q12H, Hemo- or peritoneal
dialysis: administer Q24H ,Continuous arteriovenous or hemodialysis: Administer Q8-12H. Artemisinin : no
dosage adjustment.
Prevention
• •Avoid mosquito bites:
• Wearing long sleeves, trousers.
• Avoid mosquito bites:
• Wearing long sleeves, trousers.
• Cutting over grown glass around our houses
Chemoprophylaxis
• Mefloquinine 250mg weekly (up to 1 year) or doxycycline 100mg daily
(up to 3 month), to start 1 week before and continue till 4 weeks after
leaving the area.
• Indicated for travellers travel to endemic areas.
THE END
THANK YOU
1 von 17

Recomendados

MALARIA.pptx von
MALARIA.pptxMALARIA.pptx
MALARIA.pptxAnkit Gajjar
1.1K views36 Folien
Malaria von
MalariaMalaria
MalariaDrhunny88
186 views47 Folien
Endocrine Emergencies.pptx von
Endocrine Emergencies.pptxEndocrine Emergencies.pptx
Endocrine Emergencies.pptxmunriz
28 views51 Folien
DIAGNOSIS AND MANAGEMENT OF MALARIA von
DIAGNOSIS AND MANAGEMENT OF MALARIADIAGNOSIS AND MANAGEMENT OF MALARIA
DIAGNOSIS AND MANAGEMENT OF MALARIANisheeth Patel
25.1K views46 Folien
Malaria von
MalariaMalaria
MalariaIvan Luyimbazi
12.8K views34 Folien
ICU protocol for pre-eclampsia/ eclampsia von
ICU protocol for pre-eclampsia/ eclampsiaICU protocol for pre-eclampsia/ eclampsia
ICU protocol for pre-eclampsia/ eclampsiamarwa Mahrous
7.2K views25 Folien

Más contenido relacionado

Similar a Malaria PRESENTATION.pptx

Covid 19 infection and management von
Covid 19 infection and managementCovid 19 infection and management
Covid 19 infection and managementParisha Chaudhari
518 views34 Folien
Malaria treatment guidelines von
Malaria treatment guidelinesMalaria treatment guidelines
Malaria treatment guidelinesDr. Pratyush Kumar
5.2K views21 Folien
How to manage malaria in a outpatient clinic in ethiopia von
How to manage malaria in a outpatient clinic in ethiopiaHow to manage malaria in a outpatient clinic in ethiopia
How to manage malaria in a outpatient clinic in ethiopiaDino Sgarabotto
951 views16 Folien
Toxicology Case by David Collins von
Toxicology Case by David CollinsToxicology Case by David Collins
Toxicology Case by David CollinsSMACC Conference
1.7K views28 Folien
CKD MBD - Drug Related Issues - Dr. Gawad von
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadNephroTube - Dr.Gawad
5.6K views41 Folien
Sovran rai von
Sovran raiSovran rai
Sovran raiSovranrai1
127 views58 Folien

Similar a Malaria PRESENTATION.pptx(20)

How to manage malaria in a outpatient clinic in ethiopia von Dino Sgarabotto
How to manage malaria in a outpatient clinic in ethiopiaHow to manage malaria in a outpatient clinic in ethiopia
How to manage malaria in a outpatient clinic in ethiopia
Dino Sgarabotto951 views
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID von Rooma Khalid
DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALIDDIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
Rooma Khalid17.7K views
Eclampsia labor room protocol by dr alka mukherjee dr apurva mukherjee nag... von alka mukherjee
Eclampsia   labor room protocol by dr alka mukherjee  dr apurva mukherjee nag...Eclampsia   labor room protocol by dr alka mukherjee  dr apurva mukherjee nag...
Eclampsia labor room protocol by dr alka mukherjee dr apurva mukherjee nag...
alka mukherjee250 views
Clinical management of dengue in the primary care von Andre Sookdar
Clinical management of dengue in the primary careClinical management of dengue in the primary care
Clinical management of dengue in the primary care
Andre Sookdar2.7K views
Sepsis management guidelines (SSC) 2018/2019 von Sunder Chapagain
Sepsis management guidelines (SSC) 2018/2019Sepsis management guidelines (SSC) 2018/2019
Sepsis management guidelines (SSC) 2018/2019
Sunder Chapagain36K views
The unconscious patient and patient with altered consciousness- medical von bhawesh rai
The unconscious patient and patient with altered consciousness- medicalThe unconscious patient and patient with altered consciousness- medical
The unconscious patient and patient with altered consciousness- medical
bhawesh rai1.1K views
hypercalcemia-171125132212.pdf von ssuser1944d2
hypercalcemia-171125132212.pdfhypercalcemia-171125132212.pdf
hypercalcemia-171125132212.pdf
ssuser1944d211 views
hypercalcemia-171125132212.pdf von VishnuR4970
hypercalcemia-171125132212.pdfhypercalcemia-171125132212.pdf
hypercalcemia-171125132212.pdf
VishnuR49704 views
Endocrine emergencies MCQ's/SBA von Steve Mathieu
Endocrine emergencies MCQ's/SBAEndocrine emergencies MCQ's/SBA
Endocrine emergencies MCQ's/SBA
Steve Mathieu3.4K views
Nephrotic syndrome, Characterized by heavy proteinuria>3.5g/m/day in adults,>... von FarsanaM
Nephrotic syndrome, Characterized by heavy proteinuria>3.5g/m/day in adults,>...Nephrotic syndrome, Characterized by heavy proteinuria>3.5g/m/day in adults,>...
Nephrotic syndrome, Characterized by heavy proteinuria>3.5g/m/day in adults,>...
FarsanaM230 views

Último

Recap of our Class von
Recap of our ClassRecap of our Class
Recap of our ClassCorinne Weisgerber
100 views15 Folien
Jibachha publishing Textbook.docx von
Jibachha publishing Textbook.docxJibachha publishing Textbook.docx
Jibachha publishing Textbook.docxDrJibachhaSahVetphys
53 views14 Folien
Gross Anatomy of the Liver von
Gross Anatomy of the LiverGross Anatomy of the Liver
Gross Anatomy of the Liverobaje godwin sunday
69 views12 Folien
The basics - information, data, technology and systems.pdf von
The basics - information, data, technology and systems.pdfThe basics - information, data, technology and systems.pdf
The basics - information, data, technology and systems.pdfJonathanCovena1
156 views1 Folie
Monthly Information Session for MV Asterix (November) von
Monthly Information Session for MV Asterix (November)Monthly Information Session for MV Asterix (November)
Monthly Information Session for MV Asterix (November)Esquimalt MFRC
91 views26 Folien
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant... von
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Ms. Pooja Bhandare
166 views45 Folien

Último(20)

The basics - information, data, technology and systems.pdf von JonathanCovena1
The basics - information, data, technology and systems.pdfThe basics - information, data, technology and systems.pdf
The basics - information, data, technology and systems.pdf
JonathanCovena1156 views
Monthly Information Session for MV Asterix (November) von Esquimalt MFRC
Monthly Information Session for MV Asterix (November)Monthly Information Session for MV Asterix (November)
Monthly Information Session for MV Asterix (November)
Esquimalt MFRC91 views
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant... von Ms. Pooja Bhandare
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Ms. Pooja Bhandare166 views
Narration lesson plan von TARIQ KHAN
Narration lesson planNarration lesson plan
Narration lesson plan
TARIQ KHAN64 views
How to empty an One2many field in Odoo von Celine George
How to empty an One2many field in OdooHow to empty an One2many field in Odoo
How to empty an One2many field in Odoo
Celine George97 views
Create a Structure in VBNet.pptx von Breach_P
Create a Structure in VBNet.pptxCreate a Structure in VBNet.pptx
Create a Structure in VBNet.pptx
Breach_P80 views
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx von Ms. Pooja Bhandare
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxPharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Ms. Pooja Bhandare120 views
REPRESENTATION - GAUNTLET.pptx von iammrhaywood
REPRESENTATION - GAUNTLET.pptxREPRESENTATION - GAUNTLET.pptx
REPRESENTATION - GAUNTLET.pptx
iammrhaywood151 views

Malaria PRESENTATION.pptx

  • 1. Malaria MALARIA CLINICAL PREASENTION, INVESTIGATION AND TREATMENT BY ALINISWE NG’AMBI
  • 2. How Malaria present Clinically  Stage 1(cold stage)  Chills for 15 mt to 1 hour  Caused due to rupture from the host red cells escape into Blood.  Preset with nausea, vomitting, headache  Stage 2(hot stage) • Fever may reach upto 400c may last for several hours starts invading newer red cells  Stage 3(sweating stage) • Patent starts sweating, concludes the episode • Cycles are frequently Asynchronous • Paroxysms occur every 48 – 72 hours • In P.malariae pyrexia may last for 8 hours or more and temperature my exceed 410c
  • 3. More commonly, the patient presents with a combination of the following symptoms  Chills  Sweats  Fever  Headaches  Nausea and vomiting  Body aches  General malaise.
  • 4. SEVERE COMPLICATED MALARIA  Alteration in the level of consciousness (ranging from drowsiness to deep coma)  Cerebral malaria (unarousable coma not attributable to any other cause in a patient with falciparum malaria)  Respiratory distress (metabolic acidosis bicarb less than 15 meq/l)  Multiple generalized convulsions (2 or more episodes within a 24 hour period) Shock (circulatory collapse, septicemia)  Pulmonary edema  Abnormal bleeding (Disseminated Intravascular coagulopathy)  Jaundice
  • 5. SEVERE COMPLICATED MALARIA  Haemoglobinuria (black water fever)  Acute renal failure - presenting as oliguria or anuria  Severe anaemia (Haemoglobin < 5g/dl or Haematocrit < 15%)  High fever  Hypoglycaemia (blood glucose level < 2.2.mmol/l) defined as the detection of P. falciparum in the peripheral blood
  • 6. INVESTIGATIONS AND LABS •Baseline study  CBC: Hemolytic anaemia: Hb, LDH, indirect bilirubin.  Leukocytosis or leukopenia are uncommon except in severe disease  Urinalysis:hemoglobinuria may occur with intravascular hemolysis  OTHERS; LFT and Coagulation panel to evaluate for organ funtion •Blood film examination(Microscopy) • Rapid Diagnostic Tests" (RDTs) • PCR
  • 7. BLOOD FILM(THIN AND THICK SMEAR)
  • 9. Antigen Detection • These "Rapid Diagnostic Tests" (RDTs). Rapid diagnostic tests (RDTs) are immunochromatographic tests based on detection of specific parasite antigens. Tests which detect histidine-rich protein 2 (HRP2) are specific for P.falciparum while those that detect parasite lactate dehydrogenase (pLDH)-OptiMAL
  • 10. Molecular Diagnosis • Parasite nucleic acids are detected using polymerase chain reaction (PCR). This technique is more accurate than microscopy. However, it is expensive, and requires a specialized laboratory (even though technical advances will likely result in field-operated PCR machines).
  • 11. Treatment of uncomplicated p.falciparum • Artemether plus lumefantrine( COARTEM) • Weight Tablets Day 1 Day 2 Day3 • 5-14kgs 1 tab 1 tab 1 tab then 8hr Q12H Q12H • 15-24kgs 2 tab 2 tab 2 tab then 8hr Q12H Q12H • 25-34kgs 3 tab 3 tab 3 tab then 8hr Q12H Q12H • > 34 Kgs 4 tab 4 tab 4 tab then 8hr Q12H Q12H
  • 12. Treatment of severe falciparum malaria Preferred regime • IV Artesunate (60mg): 2.4mg/kg on admission, followed by 2.4mg/kg at 12h & 24h, then once daily for 7 days. • Once the patient can tolerate oral therapy, treatment should be switched to a complete dosage of Coartem (artemether/lumefantrine) for 3 day. • Reconstitute with 5% Sodium Bicarbonate & shake 2-3min until clear solution obtained. Then add 5ml of D5% or 0.9%NaCl to create total volume of 6ml. • Slow IV injection with rate of 3-4ml/min or IM injection to the anterior thigh. The solution should be prepared freshly for each administration & should not be stored. Pregnant women & child < 8yrs old: Clindamycin (10mg/kg twice daily). Both drug can be given for 7 days • ALTERNATIVE REGIME • IV Quinine loading 7mg salt /kg over 1hr followed by infusion quinine 10mg salt/kg over 4 hrs, then 10mg salt/kg Q8H or IV Quinine 20mg/kg over 4 hrs, then 10mg/kg Q8H. PLUS • Adult and child > 8yrs old ; doxycycline( 3.5 mg/kg once daily) • Dilute injection quinine in 250ml od D5% and infused over 4hrs. • Infusion rate should not exceed 5 mg salt/kg per hour
  • 13. FOR UNDER FIVES Children under 5 kg or below 4 months should not be given Coartem instead treat with the following regimen (see table). Age Group Weight group Artesunate or *Quinine 0 - 4 months <5 kg ** IM first dose Artesunate 1.2 mg/kg or IM Arthemeter 1.6 mg/kg) ***Oral Artesunate 2mg/kg/day day 2 to day 7 Oral Quinine 10 mg/kgTDS for 4 days then 15-20 mg/kg TDS for 4 days
  • 14. SPECIFIC POPULATION • Specific Preferred regime Alternative regime populations • Pregnancy Quinine plus clindamycin to be given for Artesunate plus Clindamycin 7 day for 7 days is indicated if first line treatment fails • Lactating woman; Should receive standard antimalarial treatment (including ACTs) except for dapsone, primaquine and tetracyclines, which should be withheld during lactation • Hepatic Chloroquine: 30-50% is modified by liver, appropriate dosage adjustment impairment is needed, monitor closely. • Quinine : Mild to moderate hepatic impairment-no dosage adjustment, monitor closely. • Artemisinins : No dosage adjustment • Renal Chloroquine : ClCr<10ml/min-50% of normal dose. Impairment Hemodialysis, peritoneal dialysis: 50% of normal dose. Continuous Renal Replacement Therapy(CRRT) :100% of normal dose Quinine : .ClCr 10-50ml/min : Administer Q8-12H, CLCr<10ml/min administer Q24H ,Severe chronic renal failure not on dialysis : initial dose: 600mg followed by 300mg Q12H, Hemo- or peritoneal dialysis: administer Q24H ,Continuous arteriovenous or hemodialysis: Administer Q8-12H. Artemisinin : no dosage adjustment.
  • 15. Prevention • •Avoid mosquito bites: • Wearing long sleeves, trousers. • Avoid mosquito bites: • Wearing long sleeves, trousers. • Cutting over grown glass around our houses
  • 16. Chemoprophylaxis • Mefloquinine 250mg weekly (up to 1 year) or doxycycline 100mg daily (up to 3 month), to start 1 week before and continue till 4 weeks after leaving the area. • Indicated for travellers travel to endemic areas.